Article Listing - Alnylam and Nastech sign RNAi accord

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

Egis Pharmaceuticals is the latest Hungarian drugmaker to seek a strategic partnership as part of the on going privatization of...

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

Egis Pharmaceuticals is the latest Hungarian drugmaker to seek a strategic partnership as part of the on going privatization of...

AMA REPORT ON CONTRACEPTIVES

6 April 1992

The outcome of a report from the American Medical Association's Board of Trustees concludes that long-acting contraceptives may be medically...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

Italian raw materials sales

6 April 1992

The Italian pharmaceutical raw materials market expanded by 8% in 1991 to 2,500 billion lire ($2.1 billion), according to the...

BTG SALE COMPLETED

6 April 1992

The sale of British Technology Group by the UK government to a management and employee buy-out consortium was completed at...

DURAMED'S ISONIAZID

6 April 1992

The resurgence of tuberculosis brought about by the AIDS epidemic has caused generic drugs company Duramed Pharmaceut-icals to resume manufacture...

MILES STAFF CUTS

6 April 1992

Miles Inc of the USA is to reduce its workforce at its Diagnostics Business Group by 600, around 9%. The...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

FERMENTA INTO LOSS

6 April 1992

Swedish drugmaker Fermenta reported a 1.23 billion kroner ($203.4 million) loss for 1991, compared with a loss of 599 million...

Showing 94491-94500 of 95372 articles